You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thymoma

Showing 26 - 50 of 219
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thymoma, Masaoka Stage I, Masaoka Stage II Trial in Shanghai (the subxiphoid approach thoracoscopic thymectomy, the lateral

Not yet recruiting
  • Thymoma
  • +2 more
  • the subxiphoid approach thoracoscopic thymectomy
  • the lateral intercostal approach thoracoscopic thymectomy
  • Shanghai, China
    Shanghai Zhongshan Hospital
Aug 3, 2021

Thymic Carcinoma Trial in New York (KN046)

Recruiting
  • Thymic Carcinoma
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)

Recruiting
  • Type B3 Thymoma
  • Thymic Carcinoma
  • Milan, Italy
    National Cancer Institute
Jun 8, 2021

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

Recruiting
  • Myasthenia Gravis
  • +11 more
  • Drug treatment of myasthenia gravis and treatment of crisis
  • Assiut, Egypt
    Assiut University
Feb 22, 2022

Thymoma and Thymic Carcinoma Trial in Guangzhou (Thymosin a1, hypofractionated radiotherapy, concurrent chemoradiotherapy)

Active, not recruiting
  • Thymoma and Thymic Carcinoma
  • Thymosin a1
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 27, 2021

Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

Not yet recruiting
  • Untreated Advanced or Recurrent Thymic Carcinomas
  • Chuo, Tokyo, Japan
    National Cancer Center Hospital
Apr 16, 2023

Thymic Carcinoma Trial in Shanghai (KN046)

Recruiting
  • Thymic Carcinoma
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
May 16, 2022

Metastatic Thymic Carcinoma, Thymoma Type B3 Trial in France, Italy, Spain (Pembrolizumab, Lenvatinib 10 mg)

Recruiting
  • Metastatic Thymic Carcinoma
  • Thymoma Type B3
  • Bordeaux, France
  • +9 more
Feb 7, 2022

Thymic Carcinoma Trial in Columbus (other, biological, drug)

Recruiting
  • Thymic Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

Molecular Analysis of Thoracic Malignancies

Enrolling by invitation
  • Thymus Cancer
  • +5 more
    • Stanford, California
      Stanford University School of Medicine
    Jun 8, 2021

    NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +10 more
    • Singapore, Singapore
      Novartis Investigative Site
    Nov 16, 2022

    Prognostic Factors in Patients Submitted to Surgical Treatment

    Completed
    • Thymoma
    • +4 more
      • (no location specified)
      Oct 5, 2020

      Thymic Carcinoma, Thymoma Trial in Milan (Ramucirumab)

      Recruiting
      • Thymic Carcinoma
      • Thymoma
      • Ramucirumab
      • Milan, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Nov 12, 2020

      Thymoma and Thymic Carcinoma Trial in Xi'an (Chemotherapy+Pembrolizumab.)

      Recruiting
      • Thymoma and Thymic Carcinoma
      • Xi'an, Shaanxi, China
        Tangdu Hospital, Fourth Military Medical University
      Oct 26, 2020

      Caregiver, Malignant Pleural Tumor, Metastatic Thymic Carcinoma Trial in Columbus (Palliative Therapy, Questionnaire

      Completed
      • Caregiver
      • +11 more
      • Palliative Therapy
      • Questionnaire Administration
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Aug 11, 2022

      Thymoma, Myasthenia Gravis, Mediastinal Tumor Trial in China (Subxiphoid approach extended thymectomy by VATS, Intercostal

      Recruiting
      • Thymoma
      • +2 more
      • Subxiphoid approach extended thymectomy by VATS
      • Intercostal approach extended thymectomy by VATS
      • Haikou, Hainan, China
      • +4 more
      May 6, 2021

      Thymic Carcinoma, NSCLC, Refractory Thoracic Tumors Trial in United States (VEGFR/PDGFR Dual Kinase Inhibitor X-82, Nivolumab)

      Active, not recruiting
      • Thymic Carcinoma
      • +3 more
      • VEGFR/PDGFR Dual Kinase Inhibitor X-82
      • Nivolumab
      • Palo Alto, California
      • +6 more
      Sep 21, 2022

      Thymoma Trial in Beijing (radiotherapy)

      Unknown status
      • Thymoma
      • radiotherapy
      • Beijing, China
        Cancer hospital, Chineses Academy of Medical Sciences
      Jul 14, 2020

      Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

      Completed
      • Melanoma
      • +27 more
      • XmAb20717
      • Los Angeles, California
      • +16 more
      Nov 29, 2022

      Cardiotoxicity, Pulmonary Toxicity, Thymus Tumors Trial in Umeå, Stockholm, Gothenburg (Proton radiation)

      Recruiting
      • Cardiotoxicity
      • +2 more
      • Proton radiation
      • Umeå, Norrland, Sweden
      • +2 more
      Mar 25, 2021

      Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

      Recruiting
      • Astrocytoma
      • +22 more
      • Kogarah, New South Wales, Australia
      • +1 more
      Apr 18, 2022

      The Role of the Thymus in Myasthenia Gravis

      Completed
      • Myasthenia Gravis
      • Thymoma
        • Berlin, Germany
          Charite University (Dept of Neurology & NeuroCure Clinical Resea
        Jul 8, 2020

        Lung Cancer, Malignant Mesothelioma, Metastatic Cancer Trial in Los Angeles (radiofrequency ablation)

        Completed
        • Lung Cancer
        • +3 more
        • radiofrequency ablation
        • Los Angeles, California
          Jonsson Comprehensive Cancer Center, UCLA
        Jul 30, 2020

        Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

        Not yet recruiting
        • Neuroendocrine Tumors
        • +2 more
        • Bourdeaux, France
        • +24 more
        Jun 23, 2023